Tumour stage | Â |
---|---|
pT2 (%) | 66 (55) |
pT2a (%) | 21 (17.5) |
pT2b (%) | 3 (2.5) |
pT2c (%) | 42 (35) |
pT3 (%) | 54 (45) |
pT3a (%) | 39 (32.5) |
pT3b (%) | 15 (12.5) |
Lymph node status | Â |
PNx (%) | 94 (78.3) |
pN0 (%) | 22 (18.3) |
pN 1–2 (%) | 4 (3.3) |
Gleason score | Â |
<7 (%) | 70 (58.3) |
≥7 (%) | 50 (41.7) |
Surgical margin status | Â |
R0 (%) | 91 (75.8) |
R1 (%) | 29 (24.2) |
R1 among pT2 (%) | 4 (6.1) |
R1 among pT2a (%) | 1 (4.7) |
R1 among pT2b (%) | 0 |
R1 among pT2c (%) | 3 (7.1) |
R1 among pT3 (%) | 25 (46) |
R1 among pT3a (%) | 20 (51) |
R1 among pT3b (%) | 5 (33.3) |